Literature DB >> 15892139

Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches.

Frank A Middleton1, Carlos N Pato, Karen L Gentile, Lindsay McGann, Andrea M Brown, Marco Trauzzi, Heba Diab, Christopher P Morley, Helena Medeiros, Antonio Macedo, M Helena Azevedo, Michele T Pato.   

Abstract

We performed global RNA transcript analysis and comprehensive gene group analysis of peripheral blood leukocyte (PBL) RNA from two groups of matched sib-pairs that were discordant for either schizophrenia (n = 33 sib-pairs) or bipolar disorder (n = 5 sib-pairs). The pairs chosen for these analyses were selected from families with known patterns of genetic linkage (5q for schizophrenia and 6q for bipolar disorder). At the single gene level, we obtained lists of the transcripts with the most significant changes in expression and from these lists determined those with the highest degree of predictive power for classifying subjects according to diagnosis in these samples. At the gene group level, we comprehensively analyzed pairwise expression changes of more than 4,000 functional groups and cytogenetic locations, and present a novel method of displaying these data that we term "cytogenomic" mapping. Verification of selected changes in expression was performed using quantitative real-time RT-PCR. Our results provide compelling evidence for the utility of analyzing PBL RNA for changes in expression in neuropsychiatric disorders. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15892139     DOI: 10.1002/ajmg.b.30171

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  38 in total

1.  Regulation of leukocyte tricarboxylic acid cycle in drug-naïve Bipolar Disorder.

Authors:  Rafael T de Sousa; Emilio L Streck; Orestes V Forlenza; Andre R Brunoni; Marcus V Zanetti; Gabriela K Ferreira; Breno S Diniz; Luis V Portela; André F Carvalho; Carlos A Zarate; Wagner F Gattaz; Rodrigo Machado-Vieira
Journal:  Neurosci Lett       Date:  2015-08-20       Impact factor: 3.046

2.  Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia.

Authors:  Stephen J Glatt; Ian P Everall; William S Kremen; Jacques Corbeil; Roman Sásik; Negar Khanlou; Mark Han; Choong-Chin Liew; Ming T Tsuang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-13       Impact factor: 11.205

Review 3.  Convergent Functional Genomics of bipolar disorder: from animal model pharmacogenomics to human genetics and biomarkers.

Authors:  H Le-Niculescu; M J McFarland; S Mamidipalli; C A Ogden; R Kuczenski; S M Kurian; D R Salomon; Ming T Tsuang; J I Nurnberger; A B Niculescu
Journal:  Neurosci Biobehav Rev       Date:  2007-06-03       Impact factor: 8.989

4.  Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: evidence for circadian rhythm dysfunction in severe autism.

Authors:  Valerie W Hu; Tewarit Sarachana; Kyung Soon Kim; AnhThu Nguyen; Shreya Kulkarni; Mara E Steinberg; Truong Luu; Yinglei Lai; Norman H Lee
Journal:  Autism Res       Date:  2009-04       Impact factor: 5.216

5.  Exon Array Biomarkers for the Differential Diagnosis of Schizophrenia and Bipolar Disorder.

Authors:  Marquis Philip Vawter; Robert Philibert; Brandi Rollins; Patricia L Ruppel; Terry W Osborn
Journal:  Mol Neuropsychiatry       Date:  2018-04-10

Review 6.  Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics.

Authors:  Chi-Yu Lai; Elizabeth Scarr; Madhara Udawela; Ian Everall; Wei J Chen; Brian Dean
Journal:  World J Psychiatry       Date:  2016-03-22

Review 7.  An integrative functional genomics approach for discovering biomarkers in schizophrenia.

Authors:  Marquis P Vawter; Firoza Mamdani; Fabio Macciardi
Journal:  Brief Funct Genomics       Date:  2011-12-08       Impact factor: 4.241

8.  Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study.

Authors:  S J Glatt; S D Chandler; C A Bousman; G Chana; G R Lucero; E Tatro; T May; J B Lohr; W S Kremen; I P Everall; M T Tsuang
Journal:  Curr Pharmacogenomics Person Med       Date:  2009-09

9.  Histone methylation at H3K9: evidence for a restrictive epigenome in schizophrenia.

Authors:  Kayla A Chase; David P Gavin; Alessandro Guidotti; Rajiv P Sharma
Journal:  Schizophr Res       Date:  2013-06-28       Impact factor: 4.939

10.  Expression variation: its relevance to emergence of chronic disease and to therapy.

Authors:  Anatoly L Mayburd
Journal:  PLoS One       Date:  2009-06-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.